Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

705
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
705
Hazard Rate01:11

Hazard Rate

509
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
509
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

323
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
323
Contingency Table01:29

Contingency Table

4.9K
A contingency table provides a way of portraying data that can facilitate calculating probabilities. It is a method of displaying a frequency distribution as a table with rows and columns to show how two variables may be dependent (contingent) upon each other; The table helps determine conditional probabilities quite quickly and can help systematically organize, analyze and quantify data. The table displays sample values concerning two variables that may be dependent or contingent on one...
4.9K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

487
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
487
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

1.2K
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.

Cell host & microbe·2026
Same author

Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection.

Nature communications·2026
Same author

Searching for immune correlates in Lassa vaccine development - workshop report.

NPJ vaccines·2026
Same author

Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine.

NPJ vaccines·2026
Same author

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Nature communications·2026
Same author

Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.

Vaccine·2026
Same journal

Shared frailty sieve estimation for dependent left truncated and interval censored data.

Lifetime data analysis·2026
Same journal

Functional win-fractions regression models for composite outcomes.

Lifetime data analysis·2026
Same journal

Variable selection in causal semiparametric transformation models with all-or-nothing treatment compliance.

Lifetime data analysis·2026
Same journal

Correction to: A uniformisation-driven algorithm for inference-related estimation of a phase-type ageing model.

Lifetime data analysis·2026
Same journal

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same journal

Variable selection with broken adaptive ridge regression for interval-censored competing risks data.

Lifetime data analysis·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Mark-specific hazard ratio model with missing multivariate marks.

Michal Juraska1, Peter B Gilbert2

  • 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Mail Stop M2-C200, Seattle, WA, 98109, USA. mjuraska@fredhutch.org.

Lifetime Data Analysis
|October 30, 2015
PubMed
Summary
This summary is machine-generated.

This study addresses missing genetic data in HIV vaccine trials by developing new statistical methods. These methods improve the analysis of how vaccine efficacy relates to HIV genetic distance, even with incomplete information.

Keywords:
Augmented inverse probability weightingBiased sampling modelCompeting risksCox modelDensity ratio modelMissing dataSemiparametric model

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Related Experiment Videos

Last Updated: Mar 31, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Vaccinology

Background:

  • HIV vaccine efficacy (VE) trials aim to link vaccine protection to HIV genetic distance.
  • Genetic distance ('mark') is observed only in failures and often missing due to viral evolution.
  • Existing models struggle with missing mark data in HIV VE trial analysis.

Purpose of the Study:

  • To investigate multivariate mark-specific hazard ratio models with missing mark data.
  • To develop and evaluate two novel inferential procedures for handling missing mark data.
  • To provide generalizable methods for semiparametric models with missing data.

Main Methods:

  • Developed inverse probability weighting (IPW) of complete cases.
  • Developed IPW augmentation using auxiliary predictive data.
  • Analyzed asymptotic properties and finite-sample performance of proposed methods.
  • Applied methods to data from the HVTN 502 'Step' HIV VE trial.

Main Results:

  • The study presents two viable inferential procedures for analyzing HIV VE data with missing genetic marks.
  • Both methods demonstrate effectiveness in handling missing data under different scenarios.
  • The research validates the utility of the developed methods on real-world trial data.

Conclusions:

  • The developed statistical methods effectively address missing multivariate mark data in HIV vaccine efficacy trials.
  • These inferential procedures enhance the analysis of vaccine effects and HIV genetic distance.
  • The research offers valuable tools for future HIV vaccine studies and other fields with similar missing data challenges.